{"transactions":[{"id":2356323,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":129647,"kind":"person","name":"Wallar Gina M","position":1,"cik":"0001869819","reported_name":"Wallar Gina M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Pharma Services"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T00:56:42.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":28506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On March 1, 2022, Ms. Wallar was granted 28,506 stock options. These options vest ratably over the first four anniversary dates of the grant date."}],"balance_after":28506,"derivative":{"exercise_price":21.41,"expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":28506},"source":{"system":"sec-edgar","filing":"0001077183-22-000038","document":"wf-form4_164635538738847.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000038/wf-form4_164635538738847.xml","form_type":"4"}},{"id":2356322,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":129647,"kind":"person","name":"Wallar Gina M","position":1,"cik":"0001869819","reported_name":"Wallar Gina M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Pharma Services"}}],"security":"Common Stock","published_at":"2022-03-04T00:56:42.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":11677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 1, 2022, Ms. Wallar was granted 11,677 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance includes 104 shares that were acquired at a price of $19.16 per share pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the month ended January 31, 2022. The shares wereacquired in transactions exempt from Section 16b-3."}],"balance_after":33443,"source":{"system":"sec-edgar","filing":"0001077183-22-000038","document":"wf-form4_164635538738847.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000038/wf-form4_164635538738847.xml","form_type":"4"}},{"id":2408823,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":129647,"kind":"person","name":"Wallar Gina M","position":1,"cik":"0001869819","reported_name":"Wallar Gina M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Pharma Services"}}],"security":"Common Stock","published_at":"2022-02-09T00:12:21.000Z","date":"2021-12-31","kind":"other","acquired":true,"shares":363,"price":35.28,"value":12806.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the year ended December 31, 2021. The shares were acquired in transactions exempt from Section 16b-3."}],"balance_after":21662,"source":{"system":"sec-edgar","filing":"0001077183-22-000008","document":"wf-form5_164436552625449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000008/wf-form5_164436552625449.xml","form_type":"5"}},{"id":2456400,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":129647,"kind":"person","name":"Wallar Gina M","position":1,"cik":"0001869819","reported_name":"Wallar Gina M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Pharma Services"}}],"security":"Common Stock","published_at":"2021-12-30T23:05:44.000Z","date":"2021-12-30","kind":"grant","acquired":true,"shares":15286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 30, 2021, Ms. Wallar was granted 15,286 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022."}],"balance_after":21299,"source":{"system":"sec-edgar","filing":"0001077183-21-000280","document":"wf-form4_164090552671834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000280/wf-form4_164090552671834.xml","form_type":"4"}},{"id":2639929,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":129647,"kind":"person","name":"Wallar Gina M","position":1,"cik":"0001869819","reported_name":"Wallar Gina M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Pharma Services"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-07T23:01:41.000Z","date":"2021-07-05","kind":"grant","acquired":true,"shares":10126,"price":43.95,"value":445037.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On July 5, 2021, Ms. Wallar was granted 10,126 stock options. The options vest ratably over the first four anniversary dates of the grant date."}],"balance_after":10126,"derivative":{"exercise_price":43.95,"expiration_date":"2028-07-05","underlying":"Common Stock","underlying_shares":10126},"source":{"system":"sec-edgar","filing":"0001077183-21-000186","document":"wf-form4_162569888733988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000186/wf-form4_162569888733988.xml","form_type":"4"}},{"id":2639928,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":129647,"kind":"person","name":"Wallar Gina M","position":1,"cik":"0001869819","reported_name":"Wallar Gina M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Pharma Services"}}],"security":"Common Stock","published_at":"2021-07-07T23:01:41.000Z","date":"2021-07-05","kind":"grant","acquired":true,"shares":1896,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6013,"source":{"system":"sec-edgar","filing":"0001077183-21-000186","document":"wf-form4_162569888733988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000186/wf-form4_162569888733988.xml","form_type":"4"}}]}